Epicure 25 mg is an adjunctive anti-epileptic medication indicated for the treatment of partial-onset seizures in patients aged 4 years and older. For intravenous use, Epicure 25 mg injection is approved only for adults (16 years and above) when oral administration is temporarily not feasible.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class:
Adjunct anti-epileptic drug (AED)

Mechanism of Action:
Epicure 25 mg exhibits a high and selective affinity for synaptic vesicle protein 2A (SV2A) in the brain, which may contribute to its anticonvulsant effects. By modulating SV2A, Epicure 25 mg influences synaptic GABA release, which plays a key role in epileptogenesis. Additionally, Epicure 25 mg inhibits sodium (Na⁺) channels, further contributing to its anti-epileptic activity.

Indications:

• Partial-onset seizures in adults and pediatric patients aged 4 years and above

• Intravenous administration for adults when oral therapy is temporarily not feasible

Dosage and Administration:

• Adults (≥16 years): Start with 50 mg twice daily (100 mg/day). Adjust between 25 mg twice daily (50 mg/day) and 100 mg twice daily (200 mg/day) based on therapeutic response and tolerability.

• Pediatric patients (4–16 years): Dosage is weight-based and administered orally twice daily.

• Injection: Administer intravenously over 2–15 minutes. Inspect solution for particulate matter or discoloration before use. Single-dose administration only.

Drug Interactions:

• Rifampin: May reduce Epicure 25 mg concentrations; dose increase may be necessary.

• Carbamazepine: Monitor for increased metabolite exposure; adjust carbamazepine dose if needed.

• Phenytoin: Monitor phenytoin levels due to potential increases.

• Levetiracetam: No additional therapeutic benefit observed with combination.

Contraindications:

• Hypersensitivity to Epicure 25 mg or its inactive ingredients

Side Effects:
Common adverse reactions (≥5% and more frequent than placebo) include somnolence/sedation, dizziness, fatigue, and nausea/vomiting.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings:

• Monitor for suicidal behavior and ideation

• Neurological reactions: Advise against driving until patient adapts to therapy

• Psychiatric reactions: Monitor for irritability, depression, anxiety, or aggressive behavior

• Hypersensitivity: Discontinue immediately if bronchospasm or angioedema occurs

• Gradual withdrawal recommended to avoid seizure recurrence

Use in Special Populations:

• Pregnancy: Monitored through AED pregnancy exposure registry; limited human data

• Lactation: Unknown effects; animal studies show excretion in milk

• Hepatic impairment: Dose adjustment recommended

• Renal impairment: No dose adjustment required

Storage Conditions:
Store at 25°C (77°F); permissible range 15–30°C.